References
- 1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
- 2. Chong VF, Ong CK. Nasopharyngeal carcinoma. Eur J Radiol 2008; 66: 437-47.
- 3. Sham JS, Choy D, Choi PH. Nasopharyngeal carcinoma: the significance of neck node involvement in relation to the pattern of distant failure. Br J Radiol 1990; 63: 108-13.
- 4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AM 3rd. AJCC Cancer Staging Manual. 7th edition. New York: Springer; 2009.
- 5. Chua ML, Ong SC, Wee JT, Ng DC, Gao F, Tan TW, et al. Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma. Head Neck 2009; 31: 346-54.
- 6. NCCN guidelines for treatment of cancer by site. Head and neck cancers. Available from: http://www.nccn.org./professionals/physician_gls/f_guidelines.asp#head-and-neck, accessed on 09 October, 2013
- 7. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003; 348: 2500-7.
- 8. Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 2011; 47: 560-5.
- 9. Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, et al. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma]. [Chinese]. Ai Zheng 2007; 26: 638-42.
- 10. Lin Q, Zhao H, Zhao J, Lin C. Comparison of diagnostic value between 18F-FDG PET/CT and MRI in nasopharyngeal carcinoma. Journal of Jilin University 2009; 35: 1163-66.
- 11. King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, et al. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis. Br J Radiol 2008; 81: 291-8.
- 12. Iagaru A, Mittra ES, Gambhir SS. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning? Mol Imaging Biol 2011; 13: 362-7.
- 13. Berlin JA. Does blinding of readers affect the results of meta-analyses? University of Pennsylvania Meta-analysis Blinding Study Group. Lancet 1997; 350: 185-6.
- 14. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
- 15. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993; 12: 1293-316.
- 16. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006; 6: 31.
- 17. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003; 56: 1129-35.
- 18. Goh J, Lim K. Imaging of nasopharyngeal carcinoma. Ann Acad Med Singapore 2009; 38: 809-16.
- 19. Chen YK, Su CT, Ding HJ, Chi KH, Liang JA, Shen YY, et al. Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients. Anticancer Res 2006; 26: 1471-7.
- 20. Ng SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Staging of untreated nasopharyngeal carcinoma with PET/CT: comparison with conventional imaging work-up. Eur J Nucl Med Mol Imaging 2009; 36: 12-22.
- 21. Wu HB, Wang QS, Wang MF, Zhen X, Zhou WL, Li HS. Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT. J Nucl Med 2011; 52: 341-6.
- 22. Cai L, Zhang W, Chen Y, Huang Z. Value of 18F-FDG PET/CT and MRI for evaluating skull bone metastasis in nasopharyngeal cancer. Chongqing Medical Journal 2011; 40: 771-73.
- 23. H u WH, Zhang GY, Liu LZ, Wu HB, Li L, Gao YH, et al. [Comparison between PET-CT and MRI in diagnosing nodal metastasis of nasopharyngeal carcinoma]. [Chinese]. Ai Zheng 2005; 24: 855-60.
- 24. S u Y, Zhao C, Xie CM, Lu LX, Sun Y, Han F, et al. [Evaluation of CT, MRI and PET-CT in detecting retropharyngeal lymph node metastasis in nasopharyngeal carcinoma]. [Chinese]. Ai Zheng 2006; 25: 521-5. Z hang GY, Hu WH, Liu LZ, Wu HB, Gao YH, Li L, et al. [Comparison between PET/CT and MRI in diagnosing lymph node metastasis and N staging of nasopharyngeal carcinoma]. [Chinese]. Zhonghua Zhong Liu Za Zhi 2006; 28: 381-4.
- 25. T ang LL, Ma J, Chen Y, Zong JF, Sun Y, Wang Y, et al. [The values of MRI, CT, and PET-CT in detecting retropharyngeal lymph node metastasis of nasopharyngeal carcinoma]. [Chinese]. Ai Zheng 2007; 26: 737-41.
- 26. Lin XP, Zhao C, Chen MY, Fan W, Zhang X, Zhi SF, et al. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma]. [Chinese]. Ai Zheng 2008; 27: 974-8.
- 27. N g SH, Chan SC, Yen TC, Chang JT, Liao CT, Ko SF, et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT. Eur Radiol 2009; 19: 2965-76.
- 28. O lmi P, Fallai C, Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol Phys 1995; 32: 795-800.
- 29. R umboldt Z, Gordon L, Bonsall R, Ackermann S. Imaging in head and neck cancer. Curr Treat Options Oncol 2006; 7: 23-34.
- 30. K yzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008; 100: 712-20.
- 31. Z aidi H, Del Guerra A. An outlook on future design of hybrid PET/MRI systems. Med Phys 2011; 38: 5667-89.
- 32. L oeffelbein DJ, Souvatzoglou M, Wankerl V, Martinez-Moller A, Dinges J, Schwaiger M, et al. PET-MRI Fusion in Head-and-Neck Oncology: Current Status and Implications for Hybrid PET/MRI. J Oral Maxillofac Surg 2012; 70: 473-83.